nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Glutamine—PPAT—Fluorouracil—colon cancer	0.636	1	CbGbCtD
L-Glutamine—CAD—Pyrimidine biosynthesis—TYMS—colon cancer	0.00785	0.0842	CbGpPWpGaD
L-Glutamine—TGM4—epithelium—colon cancer	0.00562	0.0287	CbGeAlD
L-Glutamine—TGM2—endothelium—colon cancer	0.00514	0.0263	CbGeAlD
L-Glutamine—TGM2—blood vessel—colon cancer	0.00474	0.0242	CbGeAlD
L-Glutamine—TGM2—gall bladder—colon cancer	0.00446	0.0228	CbGeAlD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—ODC1—colon cancer	0.00385	0.0413	CbGpPWpGaD
L-Glutamine—NADSYN1—Nicotinate metabolism—PTGS2—colon cancer	0.00382	0.041	CbGpPWpGaD
L-Glutamine—GLS—embryo—colon cancer	0.00286	0.0146	CbGeAlD
L-Glutamine—TGM2—embryo—colon cancer	0.00283	0.0145	CbGeAlD
L-Glutamine—TGM5—vagina—colon cancer	0.00262	0.0134	CbGeAlD
L-Glutamine—GFPT2—embryo—colon cancer	0.00262	0.0134	CbGeAlD
L-Glutamine—CAD—Pyrimidine metabolism—TYMS—colon cancer	0.00259	0.0278	CbGpPWpGaD
L-Glutamine—TGM1—digestive system—colon cancer	0.0024	0.0123	CbGeAlD
L-Glutamine—GLS2—Amino acid and derivative metabolism—ODC1—colon cancer	0.00239	0.0256	CbGpPWpGaD
L-Glutamine—CCBL1—Amino acid and derivative metabolism—ODC1—colon cancer	0.00239	0.0256	CbGpPWpGaD
L-Glutamine—GLS—Amino acid and derivative metabolism—ODC1—colon cancer	0.00239	0.0256	CbGpPWpGaD
L-Glutamine—TGM2—epithelium—colon cancer	0.00231	0.0118	CbGeAlD
L-Glutamine—GATB—renal system—colon cancer	0.0023	0.0117	CbGeAlD
L-Glutamine—CCBL1—renal system—colon cancer	0.0023	0.0117	CbGeAlD
L-Glutamine—TGM3—lymphoid tissue—colon cancer	0.00227	0.0116	CbGeAlD
L-Glutamine—TGM3—digestive system—colon cancer	0.00225	0.0115	CbGeAlD
L-Glutamine—QARS—embryo—colon cancer	0.00223	0.0114	CbGeAlD
L-Glutamine—TGM2—smooth muscle tissue—colon cancer	0.00222	0.0114	CbGeAlD
L-Glutamine—TGM5—liver—colon cancer	0.00221	0.0113	CbGeAlD
L-Glutamine—GLS—renal system—colon cancer	0.00216	0.0111	CbGeAlD
L-Glutamine—TGM2—renal system—colon cancer	0.00214	0.0109	CbGeAlD
L-Glutamine—TGM1—vagina—colon cancer	0.00212	0.0108	CbGeAlD
L-Glutamine—GLS2—lymphoid tissue—colon cancer	0.00208	0.0106	CbGeAlD
L-Glutamine—NADSYN1—lymphoid tissue—colon cancer	0.00208	0.0106	CbGeAlD
L-Glutamine—CAD—embryo—colon cancer	0.00206	0.0105	CbGeAlD
L-Glutamine—GFPT2—smooth muscle tissue—colon cancer	0.00206	0.0105	CbGeAlD
L-Glutamine—NADSYN1—digestive system—colon cancer	0.00205	0.0105	CbGeAlD
L-Glutamine—GLS2—digestive system—colon cancer	0.00205	0.0105	CbGeAlD
L-Glutamine—CTPS1—renal system—colon cancer	0.00202	0.0103	CbGeAlD
L-Glutamine—GMPS—renal system—colon cancer	0.00202	0.0103	CbGeAlD
L-Glutamine—TGM3—vagina—colon cancer	0.00198	0.0101	CbGeAlD
L-Glutamine—GFPT2—renal system—colon cancer	0.00198	0.0101	CbGeAlD
L-Glutamine—TGM2—Alpha9 beta1 integrin signaling events—SRC—colon cancer	0.00197	0.0211	CbGpPWpGaD
L-Glutamine—Enlargement abdomen—Irinotecan—colon cancer	0.00196	0.0261	CcSEcCtD
L-Glutamine—GLUL—gall bladder—colon cancer	0.00195	0.00998	CbGeAlD
L-Glutamine—TGM2—Alpha9 beta1 integrin signaling events—VEGFA—colon cancer	0.00192	0.0205	CbGpPWpGaD
L-Glutamine—PPAT—Fluoropyrimidine Activity—TYMS—colon cancer	0.00184	0.0197	CbGpPWpGaD
L-Glutamine—GLS2—vagina—colon cancer	0.00181	0.00927	CbGeAlD
L-Glutamine—NADSYN1—vagina—colon cancer	0.00181	0.00927	CbGeAlD
L-Glutamine—GLS—lymphoid tissue—colon cancer	0.0018	0.00919	CbGeAlD
L-Glutamine—TGM2—lymphoid tissue—colon cancer	0.00178	0.00909	CbGeAlD
L-Glutamine—F13A1—renal system—colon cancer	0.00178	0.00908	CbGeAlD
L-Glutamine—GLS—digestive system—colon cancer	0.00178	0.00907	CbGeAlD
L-Glutamine—CTPS1—Nucleotide metabolism—TYMS—colon cancer	0.00176	0.0188	CbGpPWpGaD
L-Glutamine—TGM2—digestive system—colon cancer	0.00176	0.00898	CbGeAlD
L-Glutamine—QARS—smooth muscle tissue—colon cancer	0.00175	0.00896	CbGeAlD
L-Glutamine—SLC38A3—liver—colon cancer	0.00174	0.00892	CbGeAlD
L-Glutamine—Nail disorder—Fluorouracil—colon cancer	0.00174	0.0232	CcSEcCtD
L-Glutamine—QARS—renal system—colon cancer	0.00169	0.00863	CbGeAlD
L-Glutamine—Proctalgia—Capecitabine—colon cancer	0.00168	0.0224	CcSEcCtD
L-Glutamine—GMPS—lymphoid tissue—colon cancer	0.00167	0.00856	CbGeAlD
L-Glutamine—CCBL1—vagina—colon cancer	0.00166	0.00851	CbGeAlD
L-Glutamine—GATB—vagina—colon cancer	0.00166	0.00851	CbGeAlD
L-Glutamine—CTPS1—digestive system—colon cancer	0.00165	0.00845	CbGeAlD
L-Glutamine—GMPS—digestive system—colon cancer	0.00165	0.00845	CbGeAlD
L-Glutamine—GFPT2—lymphoid tissue—colon cancer	0.00164	0.0084	CbGeAlD
L-Glutamine—GLS—bone marrow—colon cancer	0.00164	0.00836	CbGeAlD
L-Glutamine—GLS—vagina—colon cancer	0.00157	0.00801	CbGeAlD
L-Glutamine—PFAS—Nucleotide metabolism—TYMS—colon cancer	0.00157	0.0168	CbGpPWpGaD
L-Glutamine—GMPS—Nucleotide metabolism—TYMS—colon cancer	0.00157	0.0168	CbGpPWpGaD
L-Glutamine—GLS2—liver—colon cancer	0.00153	0.00782	CbGeAlD
L-Glutamine—NADSYN1—liver—colon cancer	0.00153	0.00782	CbGeAlD
L-Glutamine—GMPS—bone marrow—colon cancer	0.00152	0.00779	CbGeAlD
L-Glutamine—CTPS1—bone marrow—colon cancer	0.00152	0.00779	CbGeAlD
L-Glutamine—PFAS—bone marrow—colon cancer	0.0015	0.00765	CbGeAlD
L-Glutamine—F13A1—lymphoid tissue—colon cancer	0.00147	0.00754	CbGeAlD
L-Glutamine—GMPS—vagina—colon cancer	0.00146	0.00746	CbGeAlD
L-Glutamine—CTPS1—vagina—colon cancer	0.00146	0.00746	CbGeAlD
L-Glutamine—F13A1—digestive system—colon cancer	0.00146	0.00745	CbGeAlD
L-Glutamine—SLC1A5—epithelium—colon cancer	0.00144	0.00737	CbGeAlD
L-Glutamine—GFPT2—vagina—colon cancer	0.00143	0.00733	CbGeAlD
L-Glutamine—PFAS—vagina—colon cancer	0.00143	0.00733	CbGeAlD
L-Glutamine—GATB—liver—colon cancer	0.0014	0.00718	CbGeAlD
L-Glutamine—CCBL1—liver—colon cancer	0.0014	0.00718	CbGeAlD
L-Glutamine—QARS—lymphoid tissue—colon cancer	0.0014	0.00717	CbGeAlD
L-Glutamine—SLC1A5—smooth muscle tissue—colon cancer	0.00139	0.0071	CbGeAlD
L-Glutamine—QARS—digestive system—colon cancer	0.00138	0.00708	CbGeAlD
L-Glutamine—GLUL—Amino acid and derivative metabolism—ODC1—colon cancer	0.00137	0.0147	CbGpPWpGaD
L-Glutamine—ASNS—Amino acid and derivative metabolism—ODC1—colon cancer	0.00137	0.0147	CbGpPWpGaD
L-Glutamine—TGM1—lymph node—colon cancer	0.00137	0.007	CbGeAlD
L-Glutamine—Gastric ulcer—Capecitabine—colon cancer	0.00136	0.0181	CcSEcCtD
L-Glutamine—F13A1—bone marrow—colon cancer	0.00134	0.00686	CbGeAlD
L-Glutamine—Haemorrhoids—Capecitabine—colon cancer	0.00134	0.0179	CcSEcCtD
L-Glutamine—SLC1A5—renal system—colon cancer	0.00134	0.00683	CbGeAlD
L-Glutamine—F13A1—Alpha9 beta1 integrin signaling events—SRC—colon cancer	0.00133	0.0143	CbGpPWpGaD
L-Glutamine—GLS—liver—colon cancer	0.00132	0.00676	CbGeAlD
L-Glutamine—TGM2—liver—colon cancer	0.00131	0.00669	CbGeAlD
L-Glutamine—F13A1—Alpha9 beta1 integrin signaling events—VEGFA—colon cancer	0.00129	0.0139	CbGpPWpGaD
L-Glutamine—F13A1—vagina—colon cancer	0.00129	0.00658	CbGeAlD
L-Glutamine—QARS—bone marrow—colon cancer	0.00128	0.00652	CbGeAlD
L-Glutamine—Bacterial infection—Methotrexate—colon cancer	0.00127	0.0169	CcSEcCtD
L-Glutamine—GLUL—embryo—colon cancer	0.00124	0.00633	CbGeAlD
L-Glutamine—GMPS—liver—colon cancer	0.00123	0.0063	CbGeAlD
L-Glutamine—CTPS1—liver—colon cancer	0.00123	0.0063	CbGeAlD
L-Glutamine—QARS—vagina—colon cancer	0.00122	0.00625	CbGeAlD
L-Glutamine—Nail disorder—Capecitabine—colon cancer	0.00122	0.0162	CcSEcCtD
L-Glutamine—GFPT2—liver—colon cancer	0.00121	0.00618	CbGeAlD
L-Glutamine—PFAS—liver—colon cancer	0.00121	0.00618	CbGeAlD
L-Glutamine—SLC7A8—renal system—colon cancer	0.0012	0.00615	CbGeAlD
L-Glutamine—ASNS—smooth muscle tissue—colon cancer	0.00119	0.00609	CbGeAlD
L-Glutamine—CAD—bone marrow—colon cancer	0.00118	0.00602	CbGeAlD
L-Glutamine—NADSYN1—lymph node—colon cancer	0.00117	0.006	CbGeAlD
L-Glutamine—GLS2—lymph node—colon cancer	0.00117	0.006	CbGeAlD
L-Glutamine—CAD—vagina—colon cancer	0.00113	0.00577	CbGeAlD
L-Glutamine—SLC1A5—lymphoid tissue—colon cancer	0.00111	0.00568	CbGeAlD
L-Glutamine—SLC1A5—digestive system—colon cancer	0.0011	0.00561	CbGeAlD
L-Glutamine—Laryngitis—Capecitabine—colon cancer	0.0011	0.0146	CcSEcCtD
L-Glutamine—PPAT—bone marrow—colon cancer	0.00109	0.00558	CbGeAlD
L-Glutamine—F13A1—liver—colon cancer	0.00109	0.00555	CbGeAlD
L-Glutamine—GATB—lymph node—colon cancer	0.00108	0.0055	CbGeAlD
L-Glutamine—CCBL1—lymph node—colon cancer	0.00108	0.0055	CbGeAlD
L-Glutamine—GFPT2—Post-translational protein modification—MUC2—colon cancer	0.00106	0.0114	CbGpPWpGaD
L-Glutamine—PPAT—vagina—colon cancer	0.00105	0.00535	CbGeAlD
L-Glutamine—TGM2—Thromboxane A2 receptor signaling—SRC—colon cancer	0.00103	0.0111	CbGpPWpGaD
L-Glutamine—QARS—liver—colon cancer	0.00103	0.00527	CbGeAlD
L-Glutamine—Sepsis—Irinotecan—colon cancer	0.00102	0.0136	CcSEcCtD
L-Glutamine—Fungal infection—Capecitabine—colon cancer	0.00102	0.0136	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—CA7—colon cancer	0.00101	0.0109	CbGpPWpGaD
L-Glutamine—GLS—lymph node—colon cancer	0.00101	0.00518	CbGeAlD
L-Glutamine—SLC1A5—bone marrow—colon cancer	0.00101	0.00517	CbGeAlD
L-Glutamine—GLUL—epithelium—colon cancer	0.00101	0.00516	CbGeAlD
L-Glutamine—CAD—Nucleotide metabolism—TYMS—colon cancer	0.00101	0.0108	CbGpPWpGaD
L-Glutamine—Sepsis—Fluorouracil—colon cancer	0.00098	0.013	CcSEcCtD
L-Glutamine—GLUL—smooth muscle tissue—colon cancer	0.000973	0.00498	CbGeAlD
L-Glutamine—SLC1A5—vagina—colon cancer	0.000968	0.00495	CbGeAlD
L-Glutamine—Rigors—Capecitabine—colon cancer	0.000967	0.0129	CcSEcCtD
L-Glutamine—Injection site pain—Capecitabine—colon cancer	0.000967	0.0129	CcSEcCtD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—BAX—colon cancer	0.000962	0.0103	CbGpPWpGaD
L-Glutamine—CAD—liver—colon cancer	0.000951	0.00486	CbGeAlD
L-Glutamine—CTPS1—lymph node—colon cancer	0.000944	0.00483	CbGeAlD
L-Glutamine—GMPS—lymph node—colon cancer	0.000944	0.00483	CbGeAlD
L-Glutamine—GLUL—renal system—colon cancer	0.000937	0.00479	CbGeAlD
L-Glutamine—GFPT2—lymph node—colon cancer	0.000927	0.00474	CbGeAlD
L-Glutamine—PFAS—lymph node—colon cancer	0.000927	0.00474	CbGeAlD
L-Glutamine—PPAT—Nucleotide metabolism—TYMS—colon cancer	0.000923	0.0099	CbGpPWpGaD
L-Glutamine—Nail disorder—Methotrexate—colon cancer	0.000906	0.0121	CcSEcCtD
L-Glutamine—TGM2—Thromboxane A2 receptor signaling—EGFR—colon cancer	0.000904	0.0097	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—CA7—colon cancer	0.000904	0.0097	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—CA7—colon cancer	0.000904	0.0097	CbGpPWpGaD
L-Glutamine—PPAT—liver—colon cancer	0.000882	0.00451	CbGeAlD
L-Glutamine—TGM2—Beta1 integrin cell surface interactions—VEGFA—colon cancer	0.000881	0.00945	CbGpPWpGaD
L-Glutamine—SLC7A8—vagina—colon cancer	0.000872	0.00446	CbGeAlD
L-Glutamine—ASNS—bone marrow—colon cancer	0.000867	0.00443	CbGeAlD
L-Glutamine—F13A1—lymph node—colon cancer	0.000832	0.00425	CbGeAlD
L-Glutamine—ASNS—vagina—colon cancer	0.000831	0.00425	CbGeAlD
L-Glutamine—NADSYN1—Metabolism—CA7—colon cancer	0.000827	0.00887	CbGpPWpGaD
L-Glutamine—Dehydration—Vincristine—colon cancer	0.000818	0.0109	CcSEcCtD
L-Glutamine—SLC1A5—liver—colon cancer	0.000817	0.00418	CbGeAlD
L-Glutamine—Dehydration—Irinotecan—colon cancer	0.000796	0.0106	CcSEcCtD
L-Glutamine—QARS—lymph node—colon cancer	0.000791	0.00404	CbGeAlD
L-Glutamine—Injection site reaction—Capecitabine—colon cancer	0.000785	0.0104	CcSEcCtD
L-Glutamine—GLUL—lymphoid tissue—colon cancer	0.000778	0.00398	CbGeAlD
L-Glutamine—SLC16A10—epithelium—colon cancer	0.00077	0.00394	CbGeAlD
L-Glutamine—GLUL—digestive system—colon cancer	0.000768	0.00393	CbGeAlD
L-Glutamine—Fungal infection—Methotrexate—colon cancer	0.000761	0.0101	CcSEcCtD
L-Glutamine—Candida infection—Capecitabine—colon cancer	0.000754	0.01	CcSEcCtD
L-Glutamine—Abdominal distension—Irinotecan—colon cancer	0.000745	0.00991	CcSEcCtD
L-Glutamine—SLC7A8—liver—colon cancer	0.000736	0.00376	CbGeAlD
L-Glutamine—NADSYN1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—colon cancer	0.000731	0.00784	CbGpPWpGaD
L-Glutamine—CAD—lymph node—colon cancer	0.000729	0.00373	CbGeAlD
L-Glutamine—Pancreatitis—Irinotecan—colon cancer	0.000726	0.00965	CcSEcCtD
L-Glutamine—GLS2—Metabolism—CA7—colon cancer	0.000723	0.00776	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—CA7—colon cancer	0.000723	0.00776	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—CA7—colon cancer	0.000723	0.00776	CbGpPWpGaD
L-Glutamine—Sweating increased—Irinotecan—colon cancer	0.000721	0.00959	CcSEcCtD
L-Glutamine—GLUL—bone marrow—colon cancer	0.000708	0.00362	CbGeAlD
L-Glutamine—ASNS—liver—colon cancer	0.000701	0.00358	CbGeAlD
L-Glutamine—Sepsis—Capecitabine—colon cancer	0.000685	0.00911	CcSEcCtD
L-Glutamine—GLUL—vagina—colon cancer	0.000679	0.00347	CbGeAlD
L-Glutamine—PPAT—lymph node—colon cancer	0.000676	0.00346	CbGeAlD
L-Glutamine—Depression—Vincristine—colon cancer	0.000676	0.00899	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Vincristine—colon cancer	0.000664	0.00884	CcSEcCtD
L-Glutamine—Hepatic function abnormal—Capecitabine—colon cancer	0.000656	0.00872	CcSEcCtD
L-Glutamine—TGM2—Thromboxane A2 receptor signaling—AKT1—colon cancer	0.000641	0.00688	CbGpPWpGaD
L-Glutamine—SLC1A5—lymph node—colon cancer	0.000626	0.0032	CbGeAlD
L-Glutamine—Neuropathy peripheral—Fluorouracil—colon cancer	0.000619	0.00824	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—ODC1—colon cancer	0.000615	0.00659	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—CHST5—colon cancer	0.000615	0.00659	CbGpPWpGaD
L-Glutamine—PPAT—Fluoropyrimidine Activity—TP53—colon cancer	0.000609	0.00653	CbGpPWpGaD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—BAX—colon cancer	0.000607	0.00651	CbGpPWpGaD
L-Glutamine—Thirst—Capecitabine—colon cancer	0.000602	0.00801	CcSEcCtD
L-Glutamine—Urinary tract disorder—Vincristine—colon cancer	0.000601	0.00799	CcSEcCtD
L-Glutamine—NADSYN1—Disease—CHST5—colon cancer	0.000598	0.00642	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—LGR5—colon cancer	0.000598	0.00642	CbGpPWpGaD
L-Glutamine—Urethral disorder—Vincristine—colon cancer	0.000596	0.00793	CcSEcCtD
L-Glutamine—F13A1—Beta1 integrin cell surface interactions—VEGFA—colon cancer	0.000595	0.00638	CbGpPWpGaD
L-Glutamine—GFPT2—Metabolism of proteins—CDX2—colon cancer	0.000594	0.00637	CbGpPWpGaD
L-Glutamine—Rhinitis—Irinotecan—colon cancer	0.000594	0.0079	CcSEcCtD
L-Glutamine—SLC16A10—lymphoid tissue—colon cancer	0.000593	0.00303	CbGeAlD
L-Glutamine—CAD—Metabolism—CA7—colon cancer	0.000583	0.00625	CbGpPWpGaD
L-Glutamine—GLUL—liver—colon cancer	0.000572	0.00293	CbGeAlD
L-Glutamine—Rhinitis—Fluorouracil—colon cancer	0.000569	0.00757	CcSEcCtD
L-Glutamine—SLC7A8—lymph node—colon cancer	0.000564	0.00288	CbGeAlD
L-Glutamine—Pharyngitis—Fluorouracil—colon cancer	0.000563	0.00749	CcSEcCtD
L-Glutamine—Angiopathy—Vincristine—colon cancer	0.000552	0.00734	CcSEcCtD
L-Glutamine—GMPS—Metabolism—CHST5—colon cancer	0.000548	0.00588	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—ODC1—colon cancer	0.000548	0.00588	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—CHST5—colon cancer	0.000548	0.00588	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—ODC1—colon cancer	0.000548	0.00588	CbGpPWpGaD
L-Glutamine—Angiopathy—Irinotecan—colon cancer	0.000537	0.00715	CcSEcCtD
L-Glutamine—ASNS—lymph node—colon cancer	0.000537	0.00275	CbGeAlD
L-Glutamine—PPAT—Metabolism—CA7—colon cancer	0.000533	0.00572	CbGpPWpGaD
L-Glutamine—Dehydration—Capecitabine—colon cancer	0.000533	0.00709	CcSEcCtD
L-Glutamine—Mental disorder—Vincristine—colon cancer	0.000533	0.00709	CcSEcCtD
L-Glutamine—Chills—Irinotecan—colon cancer	0.000532	0.00707	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—BCL2L1—colon cancer	0.000527	0.00565	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—LGR5—colon cancer	0.000523	0.00561	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CHST5—colon cancer	0.000523	0.00561	CbGpPWpGaD
L-Glutamine—SLC16A10—vagina—colon cancer	0.000517	0.00265	CbGeAlD
L-Glutamine—Back pain—Vincristine—colon cancer	0.000512	0.00681	CcSEcCtD
L-Glutamine—F13A1—Platelet degranulation—VEGFA—colon cancer	0.00051	0.00547	CbGpPWpGaD
L-Glutamine—Sepsis—Methotrexate—colon cancer	0.00051	0.00678	CcSEcCtD
L-Glutamine—Flatulence—Irinotecan—colon cancer	0.000508	0.00676	CcSEcCtD
L-Glutamine—GFPT2—Metabolism of proteins—MUC2—colon cancer	0.000505	0.00542	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—ODC1—colon cancer	0.000501	0.00538	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—CHST5—colon cancer	0.000501	0.00538	CbGpPWpGaD
L-Glutamine—Back pain—Irinotecan—colon cancer	0.000499	0.00664	CcSEcCtD
L-Glutamine—Abdominal distension—Capecitabine—colon cancer	0.000499	0.00663	CcSEcCtD
L-Glutamine—F13A1—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	0.000486	0.00521	CbGpPWpGaD
L-Glutamine—Sweating increased—Capecitabine—colon cancer	0.000482	0.00642	CcSEcCtD
L-Glutamine—Ill-defined disorder—Irinotecan—colon cancer	0.000478	0.00636	CcSEcCtD
L-Glutamine—F13A1—Platelet degranulation—TGFB1—colon cancer	0.000468	0.00502	CbGpPWpGaD
L-Glutamine—Malaise—Irinotecan—colon cancer	0.000465	0.00619	CcSEcCtD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—EP300—colon cancer	0.000463	0.00496	CbGpPWpGaD
L-Glutamine—Myalgia—Vincristine—colon cancer	0.000451	0.006	CcSEcCtD
L-Glutamine—F13A1—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	0.000446	0.00479	CbGpPWpGaD
L-Glutamine—Depression—Capecitabine—colon cancer	0.00044	0.00586	CcSEcCtD
L-Glutamine—GLUL—lymph node—colon cancer	0.000439	0.00224	CbGeAlD
L-Glutamine—GLS2—Metabolism—ODC1—colon cancer	0.000438	0.0047	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—ODC1—colon cancer	0.000438	0.0047	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—CHST5—colon cancer	0.000438	0.0047	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—CHST5—colon cancer	0.000438	0.0047	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—ODC1—colon cancer	0.000438	0.0047	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—CHST5—colon cancer	0.000438	0.0047	CbGpPWpGaD
L-Glutamine—SLC16A10—liver—colon cancer	0.000437	0.00223	CbGeAlD
L-Glutamine—Discomfort—Irinotecan—colon cancer	0.000434	0.00577	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Capecitabine—colon cancer	0.000433	0.00576	CcSEcCtD
L-Glutamine—Oedema—Vincristine—colon cancer	0.000432	0.00575	CcSEcCtD
L-Glutamine—NADSYN1—Disease—AXIN2—colon cancer	0.00043	0.00461	CbGpPWpGaD
L-Glutamine—Infection—Vincristine—colon cancer	0.000429	0.00571	CcSEcCtD
L-Glutamine—Oedema—Irinotecan—colon cancer	0.000421	0.0056	CcSEcCtD
L-Glutamine—Chest pain—Fluorouracil—colon cancer	0.00042	0.00559	CcSEcCtD
L-Glutamine—Myalgia—Fluorouracil—colon cancer	0.00042	0.00559	CcSEcCtD
L-Glutamine—Infection—Irinotecan—colon cancer	0.000418	0.00556	CcSEcCtD
L-Glutamine—Hyperhidrosis—Vincristine—colon cancer	0.000418	0.00556	CcSEcCtD
L-Glutamine—Discomfort—Fluorouracil—colon cancer	0.000415	0.00553	CcSEcCtD
L-Glutamine—GLUL—Metabolism—CA7—colon cancer	0.000415	0.00445	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CA7—colon cancer	0.000415	0.00445	CbGpPWpGaD
L-Glutamine—Hyperhidrosis—Irinotecan—colon cancer	0.000407	0.00541	CcSEcCtD
L-Glutamine—GLS—Transmission across Chemical Synapses—BRAF—colon cancer	0.000406	0.00436	CbGpPWpGaD
L-Glutamine—GLS2—Transmission across Chemical Synapses—BRAF—colon cancer	0.000406	0.00436	CbGpPWpGaD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—MYC—colon cancer	0.000403	0.00433	CbGpPWpGaD
L-Glutamine—Oedema—Fluorouracil—colon cancer	0.000403	0.00536	CcSEcCtD
L-Glutamine—Infection—Fluorouracil—colon cancer	0.0004	0.00533	CcSEcCtD
L-Glutamine—Rhinitis—Capecitabine—colon cancer	0.000397	0.00529	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000394	0.00524	CcSEcCtD
L-Glutamine—Pharyngitis—Capecitabine—colon cancer	0.000393	0.00523	CcSEcCtD
L-Glutamine—Urinary tract disorder—Capecitabine—colon cancer	0.000392	0.00521	CcSEcCtD
L-Glutamine—Insomnia—Vincristine—colon cancer	0.000391	0.0052	CcSEcCtD
L-Glutamine—Urethral disorder—Capecitabine—colon cancer	0.000389	0.00517	CcSEcCtD
L-Glutamine—Insomnia—Irinotecan—colon cancer	0.000381	0.00506	CcSEcCtD
L-Glutamine—CCBL1—Disease—AXIN2—colon cancer	0.000376	0.00403	CbGpPWpGaD
L-Glutamine—Fatigue—Vincristine—colon cancer	0.000373	0.00496	CcSEcCtD
L-Glutamine—Constipation—Vincristine—colon cancer	0.00037	0.00492	CcSEcCtD
L-Glutamine—Pain—Vincristine—colon cancer	0.00037	0.00492	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000367	0.00489	CcSEcCtD
L-Glutamine—Insomnia—Fluorouracil—colon cancer	0.000365	0.00485	CcSEcCtD
L-Glutamine—Fatigue—Irinotecan—colon cancer	0.000363	0.00483	CcSEcCtD
L-Glutamine—Pancreatitis—Methotrexate—colon cancer	0.000362	0.00481	CcSEcCtD
L-Glutamine—Constipation—Irinotecan—colon cancer	0.00036	0.00479	CcSEcCtD
L-Glutamine—Pain—Irinotecan—colon cancer	0.00036	0.00479	CcSEcCtD
L-Glutamine—Angiopathy—Capecitabine—colon cancer	0.00036	0.00479	CcSEcCtD
L-Glutamine—Chills—Capecitabine—colon cancer	0.000356	0.00473	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Vincristine—colon cancer	0.000353	0.0047	CcSEcCtD
L-Glutamine—CAD—Metabolism—CHST5—colon cancer	0.000353	0.00379	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ODC1—colon cancer	0.000353	0.00379	CbGpPWpGaD
L-Glutamine—Mental disorder—Capecitabine—colon cancer	0.000347	0.00462	CcSEcCtD
L-Glutamine—Feeling abnormal—Irinotecan—colon cancer	0.000347	0.00461	CcSEcCtD
L-Glutamine—Malnutrition—Capecitabine—colon cancer	0.000345	0.00459	CcSEcCtD
L-Glutamine—Pain—Fluorouracil—colon cancer	0.000345	0.00459	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Irinotecan—colon cancer	0.000344	0.00458	CcSEcCtD
L-Glutamine—Abdominal pain—Vincristine—colon cancer	0.000342	0.00454	CcSEcCtD
L-Glutamine—Body temperature increased—Vincristine—colon cancer	0.000342	0.00454	CcSEcCtD
L-Glutamine—Flatulence—Capecitabine—colon cancer	0.00034	0.00452	CcSEcCtD
L-Glutamine—SLC16A10—lymph node—colon cancer	0.000335	0.00171	CbGeAlD
L-Glutamine—Back pain—Capecitabine—colon cancer	0.000334	0.00444	CcSEcCtD
L-Glutamine—Abdominal pain—Irinotecan—colon cancer	0.000333	0.00443	CcSEcCtD
L-Glutamine—Body temperature increased—Irinotecan—colon cancer	0.000333	0.00443	CcSEcCtD
L-Glutamine—Feeling abnormal—Fluorouracil—colon cancer	0.000332	0.00442	CcSEcCtD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—TP53—colon cancer	0.000331	0.00355	CbGpPWpGaD
L-Glutamine—Depression—Methotrexate—colon cancer	0.000328	0.00436	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—CASP3—colon cancer	0.000326	0.00349	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CHST5—colon cancer	0.000323	0.00346	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ODC1—colon cancer	0.000323	0.00346	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—CDX2—colon cancer	0.000321	0.00344	CbGpPWpGaD
L-Glutamine—Ill-defined disorder—Capecitabine—colon cancer	0.00032	0.00426	CcSEcCtD
L-Glutamine—Body temperature increased—Fluorouracil—colon cancer	0.000319	0.00424	CcSEcCtD
L-Glutamine—Hypersensitivity—Vincristine—colon cancer	0.000318	0.00424	CcSEcCtD
L-Glutamine—GLS2—Neuronal System—BRAF—colon cancer	0.000311	0.00334	CbGpPWpGaD
L-Glutamine—GLS—Neuronal System—BRAF—colon cancer	0.000311	0.00334	CbGpPWpGaD
L-Glutamine—Malaise—Capecitabine—colon cancer	0.000311	0.00414	CcSEcCtD
L-Glutamine—Hypersensitivity—Irinotecan—colon cancer	0.00031	0.00412	CcSEcCtD
L-Glutamine—Asthenia—Vincristine—colon cancer	0.00031	0.00412	CcSEcCtD
L-Glutamine—Asthenia—Irinotecan—colon cancer	0.000302	0.00402	CcSEcCtD
L-Glutamine—QARS—Gene Expression—HNF4A—colon cancer	0.000298	0.0032	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Fluorouracil—colon cancer	0.000297	0.00395	CcSEcCtD
L-Glutamine—Myalgia—Capecitabine—colon cancer	0.000294	0.00391	CcSEcCtD
L-Glutamine—Chest pain—Capecitabine—colon cancer	0.000294	0.00391	CcSEcCtD
L-Glutamine—Arthralgia—Capecitabine—colon cancer	0.000294	0.00391	CcSEcCtD
L-Glutamine—Pharyngitis—Methotrexate—colon cancer	0.000293	0.0039	CcSEcCtD
L-Glutamine—Urinary tract disorder—Methotrexate—colon cancer	0.000291	0.00388	CcSEcCtD
L-Glutamine—Discomfort—Capecitabine—colon cancer	0.00029	0.00386	CcSEcCtD
L-Glutamine—Urethral disorder—Methotrexate—colon cancer	0.000289	0.00385	CcSEcCtD
L-Glutamine—Dry mouth—Capecitabine—colon cancer	0.000287	0.00382	CcSEcCtD
L-Glutamine—Dizziness—Vincristine—colon cancer	0.000286	0.0038	CcSEcCtD
L-Glutamine—Pruritus—Fluorouracil—colon cancer	0.000285	0.00379	CcSEcCtD
L-Glutamine—Oedema—Capecitabine—colon cancer	0.000282	0.00375	CcSEcCtD
L-Glutamine—Infection—Capecitabine—colon cancer	0.00028	0.00372	CcSEcCtD
L-Glutamine—Dizziness—Irinotecan—colon cancer	0.000278	0.0037	CcSEcCtD
L-Glutamine—Vomiting—Vincristine—colon cancer	0.000275	0.00366	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—NRAS—colon cancer	0.000273	0.00293	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—MUC2—colon cancer	0.000273	0.00293	CbGpPWpGaD
L-Glutamine—Rash—Vincristine—colon cancer	0.000272	0.00362	CcSEcCtD
L-Glutamine—Hyperhidrosis—Capecitabine—colon cancer	0.000272	0.00362	CcSEcCtD
L-Glutamine—Dermatitis—Vincristine—colon cancer	0.000272	0.00362	CcSEcCtD
L-Glutamine—Headache—Vincristine—colon cancer	0.000271	0.0036	CcSEcCtD
L-Glutamine—Angiopathy—Methotrexate—colon cancer	0.000268	0.00356	CcSEcCtD
L-Glutamine—Vomiting—Irinotecan—colon cancer	0.000268	0.00356	CcSEcCtD
L-Glutamine—Dizziness—Fluorouracil—colon cancer	0.000267	0.00355	CcSEcCtD
L-Glutamine—Rash—Irinotecan—colon cancer	0.000265	0.00353	CcSEcCtD
L-Glutamine—Dermatitis—Irinotecan—colon cancer	0.000265	0.00353	CcSEcCtD
L-Glutamine—Chills—Methotrexate—colon cancer	0.000265	0.00352	CcSEcCtD
L-Glutamine—Headache—Irinotecan—colon cancer	0.000264	0.00351	CcSEcCtD
L-Glutamine—Mental disorder—Methotrexate—colon cancer	0.000259	0.00344	CcSEcCtD
L-Glutamine—Malnutrition—Methotrexate—colon cancer	0.000257	0.00342	CcSEcCtD
L-Glutamine—Nausea—Vincristine—colon cancer	0.000257	0.00341	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000257	0.00341	CcSEcCtD
L-Glutamine—Vomiting—Fluorouracil—colon cancer	0.000256	0.00341	CcSEcCtD
L-Glutamine—Insomnia—Capecitabine—colon cancer	0.000255	0.00339	CcSEcCtD
L-Glutamine—Rash—Fluorouracil—colon cancer	0.000254	0.00338	CcSEcCtD
L-Glutamine—Dermatitis—Fluorouracil—colon cancer	0.000254	0.00338	CcSEcCtD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—SRC—colon cancer	0.000254	0.00272	CbGpPWpGaD
L-Glutamine—Headache—Fluorouracil—colon cancer	0.000253	0.00336	CcSEcCtD
L-Glutamine—GLUL—Metabolism—ODC1—colon cancer	0.000252	0.0027	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CHST5—colon cancer	0.000252	0.0027	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ODC1—colon cancer	0.000252	0.0027	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CHST5—colon cancer	0.000252	0.0027	CbGpPWpGaD
L-Glutamine—Nausea—Irinotecan—colon cancer	0.00025	0.00333	CcSEcCtD
L-Glutamine—Back pain—Methotrexate—colon cancer	0.000249	0.00331	CcSEcCtD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—NRAS—colon cancer	0.000244	0.00262	CbGpPWpGaD
L-Glutamine—Fatigue—Capecitabine—colon cancer	0.000243	0.00323	CcSEcCtD
L-Glutamine—Constipation—Capecitabine—colon cancer	0.000241	0.0032	CcSEcCtD
L-Glutamine—Pain—Capecitabine—colon cancer	0.000241	0.0032	CcSEcCtD
L-Glutamine—Nausea—Fluorouracil—colon cancer	0.000239	0.00319	CcSEcCtD
L-Glutamine—Ill-defined disorder—Methotrexate—colon cancer	0.000238	0.00317	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—KRAS—colon cancer	0.000235	0.00252	CbGpPWpGaD
L-Glutamine—GLUL—Transmission across Chemical Synapses—BRAF—colon cancer	0.000233	0.0025	CbGpPWpGaD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—SRC—colon cancer	0.000232	0.00249	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Capecitabine—colon cancer	0.000232	0.00309	CcSEcCtD
L-Glutamine—Malaise—Methotrexate—colon cancer	0.000232	0.00308	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Capecitabine—colon cancer	0.00023	0.00306	CcSEcCtD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—VEGFA—colon cancer	0.000226	0.00243	CbGpPWpGaD
L-Glutamine—Abdominal pain—Capecitabine—colon cancer	0.000223	0.00296	CcSEcCtD
L-Glutamine—Body temperature increased—Capecitabine—colon cancer	0.000223	0.00296	CcSEcCtD
L-Glutamine—Myalgia—Methotrexate—colon cancer	0.000219	0.00291	CcSEcCtD
L-Glutamine—Chest pain—Methotrexate—colon cancer	0.000219	0.00291	CcSEcCtD
L-Glutamine—Arthralgia—Methotrexate—colon cancer	0.000219	0.00291	CcSEcCtD
L-Glutamine—Discomfort—Methotrexate—colon cancer	0.000216	0.00287	CcSEcCtD
L-Glutamine—SLC1A5—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000214	0.0023	CbGpPWpGaD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—KRAS—colon cancer	0.00021	0.00225	CbGpPWpGaD
L-Glutamine—Infection—Methotrexate—colon cancer	0.000208	0.00277	CcSEcCtD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—TGFB1—colon cancer	0.000208	0.00223	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Capecitabine—colon cancer	0.000208	0.00276	CcSEcCtD
L-Glutamine—Hyperhidrosis—Methotrexate—colon cancer	0.000203	0.0027	CcSEcCtD
L-Glutamine—Asthenia—Capecitabine—colon cancer	0.000202	0.00269	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—HRAS—colon cancer	0.0002	0.00214	CbGpPWpGaD
L-Glutamine—Pruritus—Capecitabine—colon cancer	0.000199	0.00265	CcSEcCtD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—PIK3CA—colon cancer	0.000193	0.00207	CbGpPWpGaD
L-Glutamine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000191	0.00254	CcSEcCtD
L-Glutamine—Insomnia—Methotrexate—colon cancer	0.00019	0.00252	CcSEcCtD
L-Glutamine—GLS2—Transmission across Chemical Synapses—HRAS—colon cancer	0.000187	0.002	CbGpPWpGaD
L-Glutamine—GLS—Transmission across Chemical Synapses—HRAS—colon cancer	0.000187	0.002	CbGpPWpGaD
L-Glutamine—Dizziness—Capecitabine—colon cancer	0.000186	0.00248	CcSEcCtD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000182	0.00195	CbGpPWpGaD
L-Glutamine—Fatigue—Methotrexate—colon cancer	0.000181	0.0024	CcSEcCtD
L-Glutamine—Pain—Methotrexate—colon cancer	0.000179	0.00239	CcSEcCtD
L-Glutamine—Vomiting—Capecitabine—colon cancer	0.000179	0.00238	CcSEcCtD
L-Glutamine—GLUL—Neuronal System—BRAF—colon cancer	0.000179	0.00192	CbGpPWpGaD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—HRAS—colon cancer	0.000179	0.00192	CbGpPWpGaD
L-Glutamine—Rash—Capecitabine—colon cancer	0.000178	0.00236	CcSEcCtD
L-Glutamine—Dermatitis—Capecitabine—colon cancer	0.000177	0.00236	CcSEcCtD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	0.000177	0.0019	CbGpPWpGaD
L-Glutamine—Headache—Capecitabine—colon cancer	0.000176	0.00235	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—AKT1—colon cancer	0.000176	0.00189	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Methotrexate—colon cancer	0.000173	0.0023	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Methotrexate—colon cancer	0.000171	0.00228	CcSEcCtD
L-Glutamine—Nausea—Capecitabine—colon cancer	0.000167	0.00223	CcSEcCtD
L-Glutamine—Body temperature increased—Methotrexate—colon cancer	0.000166	0.00221	CcSEcCtD
L-Glutamine—Abdominal pain—Methotrexate—colon cancer	0.000166	0.00221	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—ABCB1—colon cancer	0.000162	0.00174	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—TYMS—colon cancer	0.00016	0.00171	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Methotrexate—colon cancer	0.000154	0.00206	CcSEcCtD
L-Glutamine—Asthenia—Methotrexate—colon cancer	0.00015	0.002	CcSEcCtD
L-Glutamine—Pruritus—Methotrexate—colon cancer	0.000148	0.00197	CcSEcCtD
L-Glutamine—GMPS—Metabolism—ABCB1—colon cancer	0.000145	0.00155	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—ABCB1—colon cancer	0.000145	0.00155	CbGpPWpGaD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—AKT1—colon cancer	0.000144	0.00155	CbGpPWpGaD
L-Glutamine—GLS—Neuronal System—HRAS—colon cancer	0.000143	0.00154	CbGpPWpGaD
L-Glutamine—GLS2—Neuronal System—HRAS—colon cancer	0.000143	0.00154	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—TYMS—colon cancer	0.000142	0.00153	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—TYMS—colon cancer	0.000142	0.00153	CbGpPWpGaD
L-Glutamine—Dizziness—Methotrexate—colon cancer	0.000139	0.00184	CcSEcCtD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000135	0.00144	CbGpPWpGaD
L-Glutamine—Vomiting—Methotrexate—colon cancer	0.000133	0.00177	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—ABCB1—colon cancer	0.000132	0.00142	CbGpPWpGaD
L-Glutamine—Rash—Methotrexate—colon cancer	0.000132	0.00176	CcSEcCtD
L-Glutamine—Dermatitis—Methotrexate—colon cancer	0.000132	0.00176	CcSEcCtD
L-Glutamine—Headache—Methotrexate—colon cancer	0.000131	0.00175	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—TYMS—colon cancer	0.00013	0.0014	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—PPARG—colon cancer	0.00013	0.00139	CbGpPWpGaD
L-Glutamine—Nausea—Methotrexate—colon cancer	0.000125	0.00166	CcSEcCtD
L-Glutamine—NADSYN1—Disease—FGFR3—colon cancer	0.000124	0.00133	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—EP300—colon cancer	0.000123	0.00132	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—SRC—colon cancer	0.00012	0.00129	CbGpPWpGaD
L-Glutamine—GFPT2—Metabolism of proteins—CTNNB1—colon cancer	0.000117	0.00125	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—VEGFA—colon cancer	0.000117	0.00125	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—ABCB1—colon cancer	0.000116	0.00124	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—ABCB1—colon cancer	0.000116	0.00124	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—ABCB1—colon cancer	0.000116	0.00124	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—NRAS—colon cancer	0.000115	0.00124	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—APC—colon cancer	0.000114	0.00122	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—TYMS—colon cancer	0.000114	0.00122	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—TYMS—colon cancer	0.000114	0.00122	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—TYMS—colon cancer	0.000114	0.00122	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PPARG—colon cancer	0.000113	0.00121	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—FGFR3—colon cancer	0.000109	0.00116	CbGpPWpGaD
L-Glutamine—GLUL—Transmission across Chemical Synapses—HRAS—colon cancer	0.000107	0.00115	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—BRAF—colon cancer	0.000107	0.00115	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—TGFB1—colon cancer	0.000107	0.00115	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PPARG—colon cancer	0.000101	0.00108	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PPARG—colon cancer	0.000101	0.00108	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—APC—colon cancer	9.96e-05	0.00107	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—KRAS—colon cancer	9.92e-05	0.00106	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—BRAF—colon cancer	9.36e-05	0.001	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ABCB1—colon cancer	9.33e-05	0.001	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PPARG—colon cancer	9.21e-05	0.000988	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—TYMS—colon cancer	9.16e-05	0.000983	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—PIK3CA—colon cancer	9.11e-05	0.000978	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PTGS2—colon cancer	8.89e-05	0.000954	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—TP53—colon cancer	8.82e-05	0.000946	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PTGS2—colon cancer	8.65e-05	0.000928	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ABCB1—colon cancer	8.53e-05	0.000915	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—HRAS—colon cancer	8.43e-05	0.000904	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—TYMS—colon cancer	8.38e-05	0.000899	CbGpPWpGaD
L-Glutamine—GLUL—Neuronal System—HRAS—colon cancer	8.22e-05	0.000882	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PPARG—colon cancer	8.05e-05	0.000864	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PPARG—colon cancer	8.05e-05	0.000864	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PPARG—colon cancer	8.05e-05	0.000864	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PTGS2—colon cancer	7.92e-05	0.00085	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PTGS2—colon cancer	7.92e-05	0.00085	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—ABCB1—colon cancer	7.8e-05	0.000837	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CTNNB1—colon cancer	7.74e-05	0.000831	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PTGS2—colon cancer	7.56e-05	0.000811	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CDKN1A—colon cancer	7.56e-05	0.000811	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—AKT1—colon cancer	7.44e-05	0.000799	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—EP300—colon cancer	7.39e-05	0.000793	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—MYC—colon cancer	7.39e-05	0.000792	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PTGS2—colon cancer	7.25e-05	0.000777	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—EP300—colon cancer	7.2e-05	0.000772	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—EP300—colon cancer	7.08e-05	0.000759	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—SRC—colon cancer	7e-05	0.000751	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—SRC—colon cancer	6.88e-05	0.000738	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CTNNB1—colon cancer	6.77e-05	0.000726	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—NRAS—colon cancer	6.73e-05	0.000722	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—VEGFA—colon cancer	6.7e-05	0.000719	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ABCB1—colon cancer	6.65e-05	0.000713	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ABCB1—colon cancer	6.65e-05	0.000713	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—NRAS—colon cancer	6.62e-05	0.00071	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CDKN1A—colon cancer	6.61e-05	0.000709	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—EP300—colon cancer	6.59e-05	0.000707	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—EP300—colon cancer	6.59e-05	0.000707	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—TYMS—colon cancer	6.53e-05	0.0007	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—TYMS—colon cancer	6.53e-05	0.0007	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PPARG—colon cancer	6.49e-05	0.000696	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PTGS2—colon cancer	6.33e-05	0.00068	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PTGS2—colon cancer	6.33e-05	0.00068	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PTGS2—colon cancer	6.33e-05	0.00068	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—CTNNB1—colon cancer	6.32e-05	0.000678	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—EP300—colon cancer	6.29e-05	0.000675	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MYC—colon cancer	6.27e-05	0.000673	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—TGFB1—colon cancer	6.26e-05	0.000671	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TGFB1—colon cancer	6.15e-05	0.00066	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—EGFR—colon cancer	6.13e-05	0.000658	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—SRC—colon cancer	6.12e-05	0.000656	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—EP300—colon cancer	6.03e-05	0.000647	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PPARG—colon cancer	5.94e-05	0.000637	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—NRAS—colon cancer	5.89e-05	0.000631	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—KRAS—colon cancer	5.8e-05	0.000622	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—KRAS—colon cancer	5.7e-05	0.000611	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MYC—colon cancer	5.48e-05	0.000588	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PIK3CA—colon cancer	5.47e-05	0.000587	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—TGFB1—colon cancer	5.47e-05	0.000587	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—EGFR—colon cancer	5.36e-05	0.000575	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PIK3CA—colon cancer	5.32e-05	0.000571	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—EP300—colon cancer	5.27e-05	0.000565	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—EP300—colon cancer	5.27e-05	0.000565	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—EP300—colon cancer	5.27e-05	0.000565	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—PIK3CA—colon cancer	5.23e-05	0.000561	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—AKT1—colon cancer	5.12e-05	0.000549	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PTGS2—colon cancer	5.11e-05	0.000548	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—KRAS—colon cancer	5.07e-05	0.000543	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TP53—colon cancer	5.06e-05	0.000543	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—HRAS—colon cancer	4.93e-05	0.000528	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PIK3CA—colon cancer	4.88e-05	0.000523	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PIK3CA—colon cancer	4.88e-05	0.000523	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—HRAS—colon cancer	4.84e-05	0.000519	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PTGS2—colon cancer	4.67e-05	0.000501	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PIK3CA—colon cancer	4.65e-05	0.000499	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PPARG—colon cancer	4.63e-05	0.000496	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PPARG—colon cancer	4.63e-05	0.000496	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—AKT1—colon cancer	4.47e-05	0.000479	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PIK3CA—colon cancer	4.46e-05	0.000478	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—AKT1—colon cancer	4.35e-05	0.000467	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—HRAS—colon cancer	4.31e-05	0.000462	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—AKT1—colon cancer	4.28e-05	0.000459	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—EP300—colon cancer	4.25e-05	0.000456	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—AKT1—colon cancer	3.98e-05	0.000427	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—AKT1—colon cancer	3.98e-05	0.000427	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PIK3CA—colon cancer	3.9e-05	0.000418	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PIK3CA—colon cancer	3.9e-05	0.000418	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PIK3CA—colon cancer	3.9e-05	0.000418	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—EP300—colon cancer	3.88e-05	0.000417	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—AKT1—colon cancer	3.8e-05	0.000408	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—AKT1—colon cancer	3.64e-05	0.000391	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PTGS2—colon cancer	3.64e-05	0.00039	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PTGS2—colon cancer	3.64e-05	0.00039	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—AKT1—colon cancer	3.18e-05	0.000342	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—AKT1—colon cancer	3.18e-05	0.000342	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—AKT1—colon cancer	3.18e-05	0.000342	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PIK3CA—colon cancer	3.14e-05	0.000337	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—EP300—colon cancer	3.03e-05	0.000325	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—EP300—colon cancer	3.03e-05	0.000325	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PIK3CA—colon cancer	2.87e-05	0.000308	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—AKT1—colon cancer	2.57e-05	0.000275	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—AKT1—colon cancer	2.35e-05	0.000252	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PIK3CA—colon cancer	2.24e-05	0.00024	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PIK3CA—colon cancer	2.24e-05	0.00024	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—AKT1—colon cancer	1.83e-05	0.000196	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—AKT1—colon cancer	1.83e-05	0.000196	CbGpPWpGaD
